Orchid Pharma Limited (NSE:ORCHPHARMA)

Orchid Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	70.73	211.78	36.01	225.97	43.07
Short-Term Investments	-	-	0.16	0.15	40.15	0.06
Cash & Short-Term Investments	832.11	70.73	211.94	36.16	266.12	43.13
Cash Growth	-53.68%	-66.63%	486.19%	-86.41%	517.08%	-86.32%
Accounts Receivable	-	3,814	3,531	1,955	2,152	1,706
Other Receivables	-	62.1	83	48.07	1.58	0.01
Receivables	-	3,876	3,714	2,004	2,154	1,706
Inventory	-	3,723	4,574	2,642	2,287	1,727
Prepaid Expenses	-	105.06	25.7	22.18	37.91	71.18
Other Current Assets	-	1,515	2,449	3,203	265.17	429.94
Total Current Assets	-	9,293	10,975	7,908	5,010	3,976
Property, Plant & Equipment	-	10,321	7,715	6,360	6,192	5,931
Long-Term Investments	-	669.83	599.2	458.4	444.41	454.98
Other Intangible Assets	-	736.76	170.14	149.19	3.86	3.37
Other Long-Term Assets	-	1,042	791.58	663.79	601.97	739.28
Total Assets	-	22,584	20,774	15,539	12,252	11,106

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	3,467	3,362	2,296	1,744	1,677
Accrued Expenses	-	8.04	187.59	131.62	124.31	40.03
Short-Term Debt	-	878.86	1,430	140.48	1,410	228.41
Current Portion of Long-Term Debt	-	288.16	2.66	-	415.58	369.47
Current Portion of Leases	-	3.85	3.33	3.33	-	-
Other Current Liabilities	-	266.09	101	28.55	25.85	93.04
Total Current Liabilities	-	4,912	5,087	2,600	3,719	2,408
Long-Term Debt	-	1,847	100.33	1,204	1,488	2,082
Long-Term Leases	-	47.25	0.37	3.7	-	-
Pension & Post-Retirement Benefits	-	71.28	4.07	11.94	101.13	86.86
Long-Term Deferred Tax Liabilities	-	-	-	-	32.26	32.26
Other Long-Term Liabilities	-	63.22	42.96	24.4	24.89	23.27
Total Liabilities	-	6,941	5,234	3,844	5,366	4,632

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	598.85	598.85	507.19	408.16	408.16
Additional Paid-In Capital	-	8,977	8,977	8,465	4,645	4,645
Retained Earnings	-	-11,615	-11,726	-16,180	-17,097	-17,558
Comprehensive Income & Other	-	17,681	17,689	18,902	18,931	18,979
Shareholders' Equity	12,878	15,643	15,539	11,695	6,886	6,474
Total Liabilities & Equity	-	22,584	20,774	15,539	12,252	11,106

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	3,626	3,065	1,537	1,352	3,313	2,680
Net Cash (Debt)	-2,794	-2,995	-1,325	-1,316	-3,047	-2,636
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-55.12	-50.01	-22.13	-27.20	-74.66	-64.59
Filing Date Shares Outstanding	59.71	50.72	50.72	50.72	40.82	40.82
Total Common Shares Outstanding	59.71	50.72	50.72	50.72	40.82	40.82
Working Capital	-	4,381	5,889	5,308	1,291	1,569
Book Value Per Share	253.98	308.43	306.38	230.58	168.72	158.61
Tangible Book Value	12,141	14,906	15,369	11,545	6,883	6,470
Tangible Book Value Per Share	239.45	293.90	303.03	227.64	168.62	158.53
Land	-	435.46	415.15	256.47	218.47	122.87
Buildings	-	1,977	1,950	1,849	1,783	1,439
Machinery	-	12,577	12,486	10,773	10,097	10,095
Construction In Progress	-	3,405	644.89	163.94	464.63	97.84

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 30, 2026

Data Sources Report a data error